Clinical Trial Update: Treatment for Prevention of Variceal Rebleeding Guided by the Hemodynamic Response [Phase 4]

View source ↗

Summary

Phase 4 trial evaluates a hemodynamic-response-guided treatment to prevent variceal rebleeding in patients with portal hypertension due to liver cirrhosis. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Portal Hypertension, Complications of Cirrhosis | Phase 4 | Status: UNKNOWN